Literature DB >> 9329578

Cyfra 21-1 and TPA as markers in malignant mesothelioma.

J M Bonfrer1, J H Schouwink, C M Korse, P Baas.   

Abstract

BACKGROUND: Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma.
MATERIALS AND METHODS: Serum levels of patients were analysed for prognosis of survival and follow up of disease.
RESULTS: Cyfra 21-1 and TPA have significant prognostic value for survival.
CONCLUSION: Assays measuring CK19 fragments seem to be good markers in the management of patients with malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329578

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.

Authors:  Kazuya Fukuoka; Kozo Kuribayashi; Shusai Yamada; Kunihiro Tamura; Chiharu Tabata; Takashi Nakano
Journal:  Mol Clin Oncol       Date:  2013-09-02

2.  Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma.

Authors:  Tadashi Sato; Yohei Suzuki; Takanori Mori; Masahiro Maeda; Masaaki Abe; Okio Hino; Kazuhisa Takahashi
Journal:  Cancer Med       Date:  2014-07-10       Impact factor: 4.452

Review 3.  Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.

Authors:  David T Arnold; Duneesha De Fonseka; Fergus W Hamilton; Najib M Rahman; Nick A Maskell
Journal:  Br J Cancer       Date:  2017-02-07       Impact factor: 7.640

4.  Biomarkers for early detection of malignant mesothelioma: diagnostic and therapeutic application.

Authors:  Marco Tomasetti; Lory Santarelli
Journal:  Cancers (Basel)       Date:  2010-04-14       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.